BioLife Solutions Current Ratio 2010-2024 | BLFS
BioLife Solutions current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| BioLife Solutions Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.09B | $0.03B | 2.78 |
| 2024-06-30 | $0.09B | $0.03B | 2.86 |
| 2024-03-31 | $0.11B | $0.04B | 2.89 |
| 2023-12-31 | $0.12B | $0.04B | 2.86 |
| 2023-09-30 | $0.12B | $0.04B | 2.74 |
| 2023-06-30 | $0.12B | $0.04B | 3.04 |
| 2023-03-31 | $0.13B | $0.05B | 2.81 |
| 2022-12-31 | $0.14B | $0.05B | 3.11 |
| 2022-09-30 | $0.14B | $0.04B | 3.68 |
| 2022-06-30 | $0.12B | $0.03B | 3.55 |
| 2022-03-31 | $0.12B | $0.04B | 3.39 |
| 2021-12-31 | $0.13B | $0.04B | 2.95 |
| 2021-09-30 | $0.13B | $0.04B | 3.65 |
| 2021-06-30 | $0.13B | $0.03B | 4.07 |
| 2021-03-31 | $0.12B | $0.02B | 7.12 |
| 2020-12-31 | $0.12B | $0.02B | 7.37 |
| 2020-09-30 | $0.13B | $0.01B | 15.28 |
| 2020-06-30 | $0.05B | $0.01B | 6.18 |
| 2020-03-31 | $0.03B | $0.03B | 1.04 |
| 2019-12-31 | $0.02B | $0.01B | 3.14 |
| 2019-09-30 | $0.03B | $0.01B | 6.49 |
| 2019-06-30 | $0.03B | $0.00B | 9.42 |
| 2019-03-31 | $0.04B | $0.00B | 14.50 |
| 2018-12-31 | $0.04B | $0.00B | 19.37 |
| 2018-09-30 | $0.04B | $0.00B | 18.27 |
| 2018-06-30 | $0.02B | $0.00B | 11.31 |
| 2018-03-31 | $0.01B | $0.00B | 7.81 |
| 2017-12-31 | $0.01B | $0.00B | 6.56 |
| 2017-09-30 | $0.01B | $0.00B | 5.85 |
| 2017-06-30 | $0.01B | $0.00B | 5.43 |
| 2017-03-31 | $0.01B | $0.00B | 5.14 |
| 2016-12-31 | $0.01B | $0.00B | 4.08 |
| 2016-09-30 | $0.01B | $0.00B | 1.43 |
| 2016-06-30 | $0.01B | $0.00B | 2.17 |
| 2016-03-31 | $0.01B | $0.00B | 3.59 |
| 2015-12-31 | $0.01B | $0.00B | 4.04 |
| 2015-09-30 | $0.01B | $0.00B | 5.08 |
| 2015-06-30 | $0.01B | $0.00B | 8.01 |
| 2015-03-31 | $0.01B | $0.00B | 7.49 |
| 2014-12-31 | $0.01B | $0.00B | 9.64 |
| 2014-09-30 | $0.01B | $0.00B | 15.41 |
| 2014-06-30 | $0.01B | $0.00B | 21.98 |
| 2014-03-31 | $0.02B | $0.00B | 13.79 |
| 2013-12-31 | $0.00B | $0.00B | 1.15 |
| 2013-09-30 | $0.00B | $0.00B | 1.35 |
| 2013-06-30 | $0.00B | $0.00B | 1.28 |
| 2013-03-31 | $0.00B | $0.00B | 1.30 |
| 2012-12-31 | $0.00B | $0.00B | 1.19 |
| 2012-09-30 | $0.00B | $0.00B | 1.21 |
| 2012-06-30 | $0.00B | $0.00B | 1.48 |
| 2012-03-31 | $0.00B | $0.00B | 2.00 |
| 2011-12-31 | $0.00B | $0.00B | 2.00 |
| 2011-09-30 | $0.00B | $0.00B | 2.02 |
| 2011-06-30 | $0.00B | $0.00B | 2.00 |
| 2011-03-31 | $0.00B | $0.00B | 1.98 |
| 2010-12-31 | $0.00B | $0.00B | 2.39 |
| 2010-09-30 | $0.00B | $0.01B | 0.09 |
| 2010-06-30 | $0.00B | $0.01B | 0.10 |
| 2010-03-31 | $0.00B | $0.01B | 0.09 |
| 2009-12-31 | $0.00B | $0.00B | 2.50 |
| 2009-09-30 | $0.00B | $0.01B | 0.10 |
| 2009-06-30 | $0.00B | $0.01B | 0.09 |
| 2009-03-31 | $0.00B | $0.01B | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.193B | $0.143B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |